231 related articles for article (PubMed ID: 9638470)
21. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.
Pinto AE; Fonseca I; Soares J
Cancer; 1999 Jan; 85(2):273-81. PubMed ID: 10023692
[TBL] [Abstract][Full Text] [Related]
22. Polymorphous low-grade adenocarcinoma: flow cytometric, p53, and PCNA analysis.
Kelsch RD; Bhuiya T; Fuchs A; Gentile P; Kahn MA; Fantasia JE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):391-9. PubMed ID: 9347503
[TBL] [Abstract][Full Text] [Related]
23. Immunophenotypical profiles of salivary gland tumours: a new evidence for their histogenetic origin.
Gürbüz Y; Yildiz K; Aydin O; Almaç A
Pathologica; 2006 Apr; 98(2):147-52. PubMed ID: 16929788
[TBL] [Abstract][Full Text] [Related]
24. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
25. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
Karaman CZ; Tanyeri A; Özgür R; Öztürk VS
Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812
[TBL] [Abstract][Full Text] [Related]
26. DNA flow cytometry and glial fibrillary acidic protein reactivity in pleomorphic adenomas of the salivary glands.
Desinan L; Scott CA; Pizzolitto S; Avellini C; Bardus P; Rimondi G; Rizzi V; Beltrami CA
Anal Quant Cytol Histol; 1996 Oct; 18(5):355-60. PubMed ID: 8908307
[TBL] [Abstract][Full Text] [Related]
27. Metastasizing pleomorphic adenoma with myoepithelial cell predominance.
Cresson DH; Goldsmith M; Askin FB; Reddick RL; Postma DS; Siegal GP
Pathol Res Pract; 1990 Dec; 186(6):795-800; discussion 801-2. PubMed ID: 1964734
[TBL] [Abstract][Full Text] [Related]
28. Unusual mesenchymal and mixed tumors of the salivary gland. An immunohistochemical and flow cytometric analysis of three cases.
Bocklage T; Feddersen R
Arch Pathol Lab Med; 1995 Jan; 119(1):69-74. PubMed ID: 7802557
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of parotid gland masses by rectilinear scanning.
Hendra R; Stebner FC
J Oral Surg; 1975 Nov; 33(11):838-41. PubMed ID: 171356
[TBL] [Abstract][Full Text] [Related]
30. Fatty acid synthase and Ki-67 immunoexpression can be useful for the identification of malignant component in carcinoma ex-pleomorphic adenoma.
Díaz KP; Gondak R; Martins LL; de Almeida OP; León JE; Mariano FV; Altemani A; Vargas PA
J Oral Pathol Med; 2019 Mar; 48(3):232-238. PubMed ID: 30597641
[TBL] [Abstract][Full Text] [Related]
31. Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.
Winter J; Pantelis A; Kraus D; Reckenbeil J; Reich R; Jepsen S; Fischer HP; Allam JP; Novak N; Wenghoefer M
BMC Cancer; 2012 Oct; 12():465. PubMed ID: 23050799
[TBL] [Abstract][Full Text] [Related]
32. Oncocytic and oncocytoid tumors of the salivary glands.
Paulino AF; Huvos AG
Semin Diagn Pathol; 1999 May; 16(2):98-104. PubMed ID: 10452575
[TBL] [Abstract][Full Text] [Related]
33. Comparative cytofluorometric DNA analysis of pleomorphic adenoma and adenoid cystic carcinoma of the salivary glands.
Saka T; Yamamoto Y; Takahashi H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(4):255-61. PubMed ID: 1685818
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of salivary gland tumors studied by flow cytometry.
Tytor M; Gemryd P; Wingren S; Grenko RT; Lundgren J; Lundquist PG; Nordenskjöld B
Head Neck; 1993; 15(6):514-21. PubMed ID: 8253558
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic adenoma and adenoid-cystic carcinoma of salivary glands: immunohistochemical assessment of proliferative activity in comparison with flow-cytometric study.
Daniele E; Tralongo V; Morello V; Nagar C; Russo A; Bazan V; Dardanoni G; Ciotta S; Nuara R; Tomasino RM
Cell Prolif; 1996 Mar; 29(3):153-62. PubMed ID: 8652744
[TBL] [Abstract][Full Text] [Related]
36. Benign salivary gland tumors: a cytogenetic study of 21 cases.
Martins C; Fonseca I; Félix A; Roque L; Soares J
J Surg Oncol; 1995 Dec; 60(4):232-7. PubMed ID: 8551731
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical Staining of Histological Fragments Derived from Salivary Gland Tumour Fine-Needle Biopsy Aspirates.
Lundberg M; Munsterhjelm B; Mäkitie A; Leivo I
Acta Cytol; 2017; 61(1):17-20. PubMed ID: 27880945
[TBL] [Abstract][Full Text] [Related]
38. Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma.
Silva LP; Santana T; Sedassari BT; de Sousa SM; Sobral APV; Freitas RA; Barboza CAG; de Souza LB
Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3203-3209. PubMed ID: 28523411
[TBL] [Abstract][Full Text] [Related]
39. [Proliferative activity in recurrent and nonrecurrent pleomorphic adenoma of the salivary glands].
Bankamp DG; Bierhoff E
Laryngorhinootologie; 1999 Feb; 78(2):77-80. PubMed ID: 10226990
[TBL] [Abstract][Full Text] [Related]
40. Salivary gland tumors in a Brazilian population: a retrospective study of 124 cases.
Vargas PA; Gerhard R; Araújo Filho VJ; de Castro IV
Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(6):271-6. PubMed ID: 12612759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
